Operating Lease, Right-of-Use Asset of Foghorn Therapeutics Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Foghorn Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Foghorn Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $30,949,000, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Foghorn Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $30,949,000 +$8,308,000 +37% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q3 2025 $10,178,000 -$13,891,000 -58% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $10,874,000 -$14,621,000 -57% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $21,192,000 -$7,345,000 -26% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $22,641,000 -$7,315,000 -24% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q3 2024 $24,069,000 -$7,282,000 -23% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $25,495,000 -$6,101,000 -19% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $28,537,000 -$4,350,000 -13% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $29,956,000 -$4,130,000 -12% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $31,351,000 -$4,805,000 -13% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $31,596,000 -$4,669,000 -13% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $32,887,000 -$4,515,000 -12% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $34,086,000 -$4,430,000 -12% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $36,156,000 -$3,450,000 -8.7% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $36,265,000 -$4,409,000 -11% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $37,402,000 -$4,340,000 -10% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $38,516,000 -$4,288,000 -10% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $39,606,000 -$4,296,000 -9.8% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $40,674,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $41,742,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $42,804,000 +$41,774,000 +4056% 31 Dec 2020 10-K/A 09 Aug 2022 2021 FY
Q3 2020 $43,902,000 30 Sep 2020 10-Q 04 Dec 2020 2020 Q3
Q4 2019 $1,030,000 31 Dec 2019 10-K 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.